SEC Form 4 · accession 0001179110-15-015930
Tempest Therapeutics, Inc. · TPST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arthur Tzianabos
Officer — President and CSO
Period of report
Dec 3, 2015
Accepted (ET)
Dec 7, 2015 · 5:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001544227
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Dec 3, 2015 | A | 25,000 | $0.00 | A | 25,400 | D | |
| Common Stock | holding | — | — | — | 1,000 | I | by IRA |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Each restricted stock unit ("RSU") represents the right to receive one share of common stock upon vesting. The RSU vests as to 25% of the shares on December 3, 2016 and as to an additional 6.25% of the shares each successive three-month period thereafter, until December 3, 2019.
- F2Represents 400 shares of common stock and 25,000 RSUs.